Sanofi Gets EU Nod on Hemolytic Anemia Drug

(marketscreener.com) By Cecilia Butini Sanofi SA said Thursday that the European Union gave marketing authorization to a drug it developed to treat hemolytic anemia in adult patients with cold agglutinin disease, an autommune disease targeting red blood cells. The French pharma company said that its drug, a monoclonal antibody named Enjaymo, is currently...https://www.marketscreener.com/quote/stock/SANOFI-4698/news/Sanofi-Gets-EU-Nod-on-Hemolytic-Anemia-Drug-42347186/?utm_medium=RSS&utm_content=20221117